These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32260912)

  • 21. Intrinsically fluorescent silica nanocontainers: a promising theranostic platform.
    Rodrigues AS; Ribeiro T; Fernandes F; Farinha JP; Baleizão C
    Microsc Microanal; 2013 Oct; 19(5):1216-21. PubMed ID: 23800692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of organic-inorganic hybrid microspheres and the corresponding mesoporous silica nanoparticles.
    Liu B; Fu X; Wang D; Zhang W; Yang X
    J Colloid Interface Sci; 2013 Dec; 411():98-104. PubMed ID: 24055252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid, protein and poly(NIPAM) coated mesoporous silica nanoparticles for biomedical applications.
    Yang Y; Li J
    Adv Colloid Interface Sci; 2014 May; 207():155-63. PubMed ID: 24268194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release.
    Trewyn BG; Slowing II; Giri S; Chen HT; Lin VS
    Acc Chem Res; 2007 Sep; 40(9):846-53. PubMed ID: 17645305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrazine Degradation Using Immobilized Triazine Hydrolase from
    Diviesti K; Russell-Parks GA; Trewyn BG; Holz RC
    ACS Environ Au; 2023 Nov; 3(6):361-369. PubMed ID: 38028742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins.
    Tu J; Boyle AL; Friedrich H; Bomans PH; Bussmann J; Sommerdijk NA; Jiskoot W; Kros A
    ACS Appl Mater Interfaces; 2016 Nov; 8(47):32211-32219. PubMed ID: 27933855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Elucidation of Biological Response to Mesoporous Silica Nanoparticles in Vitro and in Vivo.
    Chou CC; Chen W; Hung Y; Mou CY
    ACS Appl Mater Interfaces; 2017 Jul; 9(27):22235-22251. PubMed ID: 28608695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting.
    Bouchoucha M; Béliveau É; Kleitz F; Calon F; Fortin MA
    J Mater Chem B; 2017 Oct; 5(37):7721-7735. PubMed ID: 32264373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
    Biswas N
    Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BMMNCs Cell.
    Chauhan S; Manivasagam G; Kumar P; Ambasta RK
    Pharm Nanotechnol; 2018; 6(4):245-252. PubMed ID: 30381088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Well-defined functional mesoporous silica/polymer hybrids prepared by an ICAR ATRP technique integrated with bio-inspired polydopamine chemistry for lithium isotope separation.
    Liu Y; Liu X; Ye G; Song Y; Liu F; Huo X; Chen J
    Dalton Trans; 2017 May; 46(18):6117-6127. PubMed ID: 28436505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.
    Farooq A; Shukur A; Astley C; Tosheva L; Kelly P; Whitehead D; Azzawi M
    Acta Biomater; 2018 Aug; 76():208-216. PubMed ID: 29933106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface pH buffering to promote degradation of mesoporous silica nanoparticles under a physiological condition.
    Choi E; Kim S
    J Colloid Interface Sci; 2019 Jan; 533():463-470. PubMed ID: 30172772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.
    Su J; Sun H; Meng Q; Zhang P; Yin Q; Li Y
    Theranostics; 2017; 7(3):523-537. PubMed ID: 28255347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.